Please assess the completion status of the following clinical trial:

Trial Title: Supplementary Epidural Analgesia in Video-Assisted Thoracic Surgery (VATS) - The SEAVATS Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Planned elective VATS lobectomy, wedge- or segmental resection. (for the subsequent biomarker study, only lobectomy is a inclusion criteria, specified in protocol amendment July 27th 2016)~* Patient has accepted to have epidural analgesia as part of the anaesthesia for the procedure.~* Informed consent is attained.~* Patient is over 18 years of age.~* Patient is mentally able to answer questionnaires included in the study.~Exclusion Criteria:~* Allergies to any of the medications used in the trial.~* History of previous peptic ulcer.~* History of chronic pain to any degree that will interfere with quantification of pain postoperatively.~* Dementia or reduced mental capacity to any degree that will interfere with quantification of pain postoperatively.~* Pregnancy.~* Contra-indications to placement of epidural catheter.~* Any concurrent cancer disease or use of immune modulating drugs (criteria added as part of a protocol amendment July 27th 2016 for a subsequent biomarkers study)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Active Epidural analgesia (Type: ACTIVE_COMPARATOR): Epidural catheter: Bupivacain 1,0 mg/ml + Fentanyl 2 micrograms/ml. Oral analgesia: Paracetamol, NSAID and placebo tablets.
- Placebo Epidural analgesia (Type: ACTIVE_COMPARATOR): Epidural analgesia: Placebo. Oral analgesia: Paracetamol, NSAID and opioids tablets.

Based on this trial design, predict the completion outcome and termination type (if applicable).